Frontlight ResearchEarly access
Trial site
Institutul Inimii De Urgenta Pentru Boli Cardiovasculare Niculae Stancioiu
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- High blood pressure6 trials
- Pulmonary arterial hypertension6 trials
- Amyloidosis1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- United Therapeutics2 trials
- Alnylam Pharmaceuticals1 trial
- Bayer AG1 trial
- GB002, Inc.1 trial
- Gossamer Bio USA, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Amyloidosis1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026